The use of rituximab and bendamustine in treating chronic lymphocytic leukaemia (CLL) in end-stage renal disease (ESRD)

Document Type

Journal Article

Publication Date

5-2-2013

Journal

BMJ Case Reports

Peer Reviewed

1

Share

COinS